Within IBM Watson Health we strive to lead with science, and we are proud to report several significant accomplishments in the first quarter of 2019. The business continues its long investment in scientific excellence and has recruited a talented group of biomedical informaticians, clinicians, program managers, research coordinators, data scientists, and writers to expand our Center for AI, Research, and Evaluation (CARE). Our center seeks to integrate research activities and generate high quality scientific evidence to support the performance and impact of Watson Health solutions. 

Specifically, the goals of the center are:
  • To design, conduct, and disseminate results of rigorous scientific research related to Watson Health offerings
  • To support collaboration among design / development teams, IBM Research scientists, academic institutions, and client partners
  • To lead in the science of health informatics, especially artificial intelligence and implementation science

At HIMSS 2019 we announced two long-term academic research collaborations with Vanderbilt University Medical Center and the Brigham and Women’s Hospital, demonstrating IBM Watson Health’s investment in the advancement of AI in health and healthcare. By partnering with these renowned academic institutions we will build a long-term relationship with leading biomedical informaticians and collaborate on studies about our products and thought leadership efforts in the fields of AI, health informatics, patient safety, precision medicine, and health equity. Our center looks forward to supporting collaborations internally within IBM and externally with our academic and client partners to yield the highest quality science.

This work builds on IBM’s longstanding commitment to leading with science and research. In 1945 IBM formally established IBM Research, which has enabled scientists to transform industries and society for the past seven decades. IBM employs over 3,000 scientists across 6 continents. Additionally, IBM has led the industry for 26 consecutive years in US patents, with over 9,100 accepted in 2018. We are proud of the people who continue to progress science across industries, including the six IBM associated employees who have received Nobel laureates over the years, the most recent, former IBM Research scientist and 2014 Nobel Prize winner Dr. W.E. Moerner who received his award commemorating his pioneering achievements in chemistry. Most recently, IBM has invested $240M to advance artificial intelligence, software and algorithms in our partnership with MIT at the MIT-IBM Watson AI Lab.

In this first quarter of 2019 IBM scientists have produced over 85 contributions to the scientific literature in a wide variety of health and healthcare domains, as summarized below. We look forward to keeping you updated on our scientific journey!